Venture Capital Investors

HealthCare Ventures

HealthCare Ventures invests in innovation by backing techn-focused companies.

Venture Investor Overview

Venture Investor
HealthCare Ventures
Status
InActive
Investor Type
Venture Capital
Activity Level
139 transactions
Funds Raised
At least $902 million
Industry Focus
Life Sciences

Contact Information

Contact
Augustine Lawlor
Title
Partner
Mailing Address
47 Thorndike St. B1-1
Cambridge, MA 02141
USA
Phone
(617) 252-4343
Website
www.hcven.com
Email Address
[email protected]

Background Information

Overview
HealthCare Ventures is a leading venture capital firm specializing in life science industry investing. At HealthCare Ventures we concentrate our investment dollars on life science companies showing high growth potential. Since 1985, we have maintained a constant objective to support entrepreneurs and to generate above average returns for our limited partners.
Profile
HealthCare Ventures LinkedIn Company Profile
Social Media
HealthCare Ventures Company Twitter Account
Company News
HealthCare Ventures News
Facebook
HealthCare Ventures on Facebook
YouTube
HealthCare Ventures on YouTube
Last Transaction
6/21/2022

Transaction History

Our records indicate that HealthCare Ventures invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
MyOme
6/21/2022
$23,000,000
Paige.AI
12/19/2019
$45,000,000
Colorescience
7/21/2017
$15,000,000
Proteostasis Therapeutics
9/9/2015
$37,000,000
Vaxxas
2/10/2015
$20,000,000
Senseonics
6/6/2014
$20,000,000
PathoGenetix
10/30/2013
$10,000,000
Theraclone Sciences
9/30/2013
$4,000,000
InfaCare Pharmaceutical
3/31/2013
$3,312,000
Catalyst Biosciences
3/31/2013
$5,072,000
Theraclone Sciences
3/25/2013
$14,000,000
DecImmune Therapeutics
1/17/2013
$2,250,000
Synovex
12/31/2012
$1,062,900
GITR
12/31/2012
$1,000,000
Cleveland Heartlab
10/22/2012
$14,700,000
Seahorse Bioscience
9/30/2012
$11,357,000
Apofore
9/30/2012
$1,000,000
Synovex
9/30/2012
$2,437,000
Dekkun
9/30/2012
$3,500,000
GITR
6/12/2012
$1,000,000
Tensha Therapeutics
3/31/2012
$1,000,000
NanoMR
3/31/2012
$6,500,000
Promedior
3/8/2012
$21,500,000
Theraclone Sciences
12/31/2011
$985,200
Senseonics
11/1/2011
$54,100,000
PathoGenetix
11/1/2011
$7,500,000
Shape Pharmaceuticals
9/30/2011
$1,000,000
Anchor Therapeutics
9/30/2011
$3,000,000
Apofore
9/30/2011
$500,000
Tensha Therapeutics
9/13/2011
$15,000,000
Theraclone Sciences
9/8/2011
$10,600,000
Cleveland Heartlab
8/22/2011
$18,400,000
Mosaic Biosciences
7/22/2011
$1,030,462
NanoMR
7/19/2011
$13,000,000
Proteostasis Therapeutics
6/30/2011
$25,623,000
Radius Health
5/24/2011
$91,000,000
Dekkun
1/10/2011
$9,930,400
TetraLogic Pharmaceuticals
1/5/2011
$23,000,000
Proteostasis Therapeutics
12/31/2010
$23,000,000
VaxInnate
12/31/2010
$14,000
Synovex
12/31/2010
$5,000,000
Galleon Pharmaceuticals
12/31/2010
$10,000,100
DecImmune Therapeutics
9/27/2010
$1,000,000
Anchor Therapeutics
8/20/2010
$10,000,000
TetraLogic Pharmaceuticals
8/11/2010
$32,000,000
Trevena
7/14/2010
$35,000,000
Senseonics
6/30/2010
$10,000,000
Arresto Biosciences
6/30/2010
$8,050,000
FoldRx Pharmaceuticals
6/15/2010
$29,000,000
GlobeImmune
3/31/2010
$17,508,500
Promedior
3/16/2010
$12,000,000
Seahorse Bioscience
2/23/2010
$5,000,000
Shape Pharmaceuticals
12/31/2009
$3,889,000
Promedior
9/30/2009
$7,000,000
Anexon
9/30/2009
$2,000,000
GlobeImmune
6/30/2009
$571,000
SkinMedica
6/30/2009
$4,924,000
Proteostasis Therapeutics
6/30/2009
$7,556,000
Trevena
6/30/2009
$11,000,000
Synovex
6/30/2009
$1,490,000
Anchor Therapeutics
6/30/2009
$10,000,000
Xanodyne Pharmaceuticals
6/4/2009
$38,000,000
VaxInnate
5/6/2009
$30,000,000
Achievo
3/31/2009
$3,758,000
Sierra Neuropharmaceuticals
3/31/2009
$1,500,000
Promedior
3/31/2009
$7,163,000
Stemgent
3/9/2009
$14,000,000
Surface Logix
3/9/2009
$20,000,000
Anchor Therapeutics
12/31/2008
$9,999,900
Galleon Pharmaceuticals
12/31/2008
$15,000,000
Oriel Therapeutics
12/31/2008
$15,000,000
Shape Pharmaceuticals
12/31/2008
$1,000,000
Catalyst Biosciences
12/3/2008
$40,400,000
Radius Health
11/20/2008
$15,000,000
InfaCare Pharmaceutical
10/27/2008
$28,000,000
Vitals.com
10/14/2008
$4,000,000
Proteostasis Therapeutics
8/25/2008
$45,000,000
Sierra Neuropharmaceuticals
7/31/2008
$21,500,000
Promedior
6/30/2008
Unknown
Synovex
6/30/2008
$500,000
Potentia Pharmaceuticals
4/9/2008
$12,000,000
Stemgent
3/31/2008
$1,000,000
Trevena
3/5/2008
$24,000,000
Promedior
2/4/2008
$7,000,000
Anexon
12/31/2007
$500,000
Catalyst Biosciences
12/31/2007
$13,480,000
Synovex
12/31/2007
$1,000,000
Sierra Neuropharmaceuticals
12/31/2007
$855,000
Arresto Biosciences
12/31/2007
$16,000,000
ProteoGuard
12/31/2007
$75,000
Oriel Therapeutics
11/16/2007
$23,000,000
Bikam Pharmaceuticals
11/2/2007
$3,640,000
Anchor Therapeutics
11/2/2007
$8,000,000
Achievo
9/30/2007
$34,000,000
GlobeImmune
9/26/2007
$41,200,000
Xanodyne Pharmaceuticals
7/27/2007
$25,000,000
ProteoGuard
6/30/2007
$627,000
Visionary Therapeutics
3/31/2007
Unknown
FoldRx Pharmaceuticals
3/31/2007
$32,251,300
Theraclone Sciences
3/19/2007
$29,000,000
Sequoia Pharmaceuticals
1/9/2007
$35,000,000
Xanthus Pharmaceuticals
12/1/2006
$25,000,000
VaxInnate
10/25/2006
$40,000,000
Xencor
10/23/2006
$45,000,000
DecImmune Therapeutics
9/30/2006
$2,085,000
Promedior
9/5/2006
$7,000,000
Medior
9/5/2006
$7,000,000
TolerRx
8/16/2006
$35,600,000
Radianse
7/13/2006
$6,000,000
Synovex
6/30/2006
$1,600,000
TetraLogic Pharmaceuticals
6/12/2006
$36,000,000
FoldRx Pharmaceuticals
5/31/2006
$43,000,000
Avidia
5/9/2006
$43,800,000
Cardiokine
5/1/2006
$50,000,000
SkinMedica
4/11/2006
$11,000,000
Xanthus Pharmaceuticals
3/31/2006
$10,000,000
Catalyst Biosciences
2/9/2006
$30,000,000
GlobeImmune
1/10/2006
$38,400,000
Senseonics
11/2/2005
$30,000,000
GlobeImmune
9/14/2005
$34,300,000
Cardiovascular Systems
9/8/2005
$62,500,000
SkinMedica
4/6/2005
$15,000,000
TolerRx
3/29/2005
$31,000,000
FoldRx Pharmaceuticals
12/13/2004
$16,000,000
Catalyst Biosciences
12/4/2004
$40,000,000
Radianse
12/2/2004
$11,000,000
PharmAthene
10/12/2004
$50,000,000
Cardiovascular Systems
8/17/2004
$40,000,000
SkinMedica
7/14/2004
$40,000,000
TetraLogic Pharmaceuticals
6/29/2004
$8,000,000
Gentara
6/29/2004
$4,000,000
Xanodyne Pharmaceuticals
6/1/2004
$20,000,000
Cardiokine
4/13/2004
$37,000,000
Xanthus Pharmaceuticals
12/12/2003
$30,800,000
Critical Technologies
10/8/2003
$56,000,000
ActivBiotics
8/4/2003
$26,400,000
Cellgate
6/1/2003
$43,000,000
GlobeImmune
4/18/2003
$8,000,000
TolerRx
1/3/2003
$35,000,000

 

Investor Contacts

Title
Name
Email & Social
Partner
Augustine Lawlor
  Augustine Lawlor LinkedIn Profile  Augustine Lawlor Twitter Account  Augustine Lawlor News  Augustine Lawlor on Facebook
Partner
Christopher Mirabelli
  Christopher Mirabelli LinkedIn Profile  Christopher Mirabelli Twitter Account  Christopher Mirabelli News  Christopher Mirabelli on Facebook
Partner
Douglas Onsi
  Douglas Onsi LinkedIn Profile  Douglas Onsi Twitter Account  Douglas Onsi News  Douglas Onsi on Facebook

 

Funds

Our database includes the following fund closing(s) for HealthCare Ventures. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
HealthCare Ventures IX
9/30/2010
$250,000,000
HealthCare Ventures VIII
8/10/2005
$375,000,000
HealthCare Ventures VII
10/28/2002
$277,000,000

 

Portfolio Companies

HealthCare Ventures has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Achievo
ActivBiotics
Anchor Therapeutics
Anexon
Apofore
Arresto Biosciences
Avidia
Bikam Pharmaceuticals
Cardiokine
Cardiovascular Systems
Catalyst Biosciences
Cellgate
Cleveland Heartlab
Colorescience
Critical Technologies
DecImmune Therapeutics
Dekkun
FoldRx Pharmaceuticals
Galleon Pharmaceuticals
Gentara
GITR
GlobeImmune
InfaCare Pharmaceutical
Medior
Mosaic Biosciences
MyOme
NanoMR
Oriel Therapeutics
Paige.AI
PathoGenetix
PharmAthene
Potentia Pharmaceuticals
Promedior
ProteoGuard
Proteostasis Therapeutics
Radianse
Radius Health
Seahorse Bioscience
Senseonics
Sequoia Pharmaceuticals
Shape Pharmaceuticals
Sierra Neuropharmaceuticals
SkinMedica
Stemgent
Surface Logix
Synovex
Tensha Therapeutics
TetraLogic Pharmaceuticals
Theraclone Sciences
TolerRx
Trevena
VaxInnate
Vaxxas
Visionary Therapeutics
Vitals.com
Xanodyne Pharmaceuticals
Xanthus Pharmaceuticals
Xencor

 

 

 

 

Browse more venture capital investors:

HealthCare Royalty Partners | HealthInvest Equity Partners

 

Share this article

 

About Our VC Investors Database

The venture capital investor data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.